Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients
Medical records were reviewed retrospectively to determine if the decreased dosing frequency of cotrimoxazole maintained efficacy and reduced adverse reactions in HIV-positive patients with Pneumocystis carinii pneumonia (PCP).
Gespeichert in:
| Veröffentlicht in: | The American journal of medicine 1992-02, Vol.92 (2), p.227-229 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 229 |
|---|---|
| container_issue | 2 |
| container_start_page | 227 |
| container_title | The American journal of medicine |
| container_volume | 92 |
| creator | MacGregor, Rob Roy Morgan, Amy S. Graziani, Amy L. Pietroski, Nancy A. Frank, Ian Braffman, Michael N. Stern, John J. Buckley, R.Michael |
| description | Medical records were reviewed retrospectively to determine if the decreased dosing frequency of cotrimoxazole maintained efficacy and reduced adverse reactions in HIV-positive patients with Pneumocystis carinii pneumonia (PCP). |
| doi_str_mv | 10.1016/0002-9343(92)90122-R |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72836080</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000293439290122R</els_id><sourcerecordid>72836080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-4b4c9ff8a75e5ba63d3425bcafc5fc91c227e97f0401621592b0bf2bc9a696743</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhoModVv9BwpBRPRiaj5nJjcFWWpbKLQU9TZkMieYMjsZk8zS9dc3wy4teOHVIZznvJw8B6F3lJxSQuuvhBBWKS74Z8W-KEIZq-5eoBWVUlYNrdlLtHpCXqPjlO7LkyhZH6EjKgVnVKzQeO6ct8busBl7nMMA0YwWcHDYjxnixucMY8ZbiGlOuDd-2GEbcvSb8GD-Fh67EPHt-hZPMUy_d4N58KnM4surX9UUks9-C3gy2ZeY9Aa9cmZI8PZQT9DP7-c_1pfV9c3F1frbdWUF5bkSnbDKudY0EmRnat5zwWRnjbPSWUUtYw2oxhFRRDAqFetI51hnlalV3Qh-gj7tc8tSf2ZIWW98sjAMZoQwJ92wltekJQX88A94H-Y4lt0044wT1aolTewhG0NKEZyeyv9N3GlK9HILvYjWi2itSl1uoe_K2PtD9txtoH8e2ssv_Y-HvknWDG4x79MTJplUUrUFO9tjUIRtPUSdbJFpofcRbNZ98P_f4xEwJaYk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232309894</pqid></control><display><type>article</type><title>Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>MacGregor, Rob Roy ; Morgan, Amy S. ; Graziani, Amy L. ; Pietroski, Nancy A. ; Frank, Ian ; Braffman, Michael N. ; Stern, John J. ; Buckley, R.Michael</creator><creatorcontrib>MacGregor, Rob Roy ; Morgan, Amy S. ; Graziani, Amy L. ; Pietroski, Nancy A. ; Frank, Ian ; Braffman, Michael N. ; Stern, John J. ; Buckley, R.Michael</creatorcontrib><description>Medical records were reviewed retrospectively to determine if the decreased dosing frequency of cotrimoxazole maintained efficacy and reduced adverse reactions in HIV-positive patients with Pneumocystis carinii pneumonia (PCP).</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/0002-9343(92)90122-R</identifier><identifier>PMID: 1543214</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; AIDS/HIV ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiparasitic agents ; Biological and medical sciences ; Drug Administration Schedule ; Drugs ; HIV Infections - complications ; Humans ; Medical research ; Medical sciences ; Pharmacology. Drug treatments ; Pneumonia ; Pneumonia, Pneumocystis - etiology ; Pneumonia, Pneumocystis - prevention & control ; Retrospective Studies ; Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use</subject><ispartof>The American journal of medicine, 1992-02, Vol.92 (2), p.227-229</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Feb 1992</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-4b4c9ff8a75e5ba63d3425bcafc5fc91c227e97f0401621592b0bf2bc9a696743</citedby><cites>FETCH-LOGICAL-c413t-4b4c9ff8a75e5ba63d3425bcafc5fc91c227e97f0401621592b0bf2bc9a696743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/000293439290122R$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5259598$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1543214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MacGregor, Rob Roy</creatorcontrib><creatorcontrib>Morgan, Amy S.</creatorcontrib><creatorcontrib>Graziani, Amy L.</creatorcontrib><creatorcontrib>Pietroski, Nancy A.</creatorcontrib><creatorcontrib>Frank, Ian</creatorcontrib><creatorcontrib>Braffman, Michael N.</creatorcontrib><creatorcontrib>Stern, John J.</creatorcontrib><creatorcontrib>Buckley, R.Michael</creatorcontrib><title>Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Medical records were reviewed retrospectively to determine if the decreased dosing frequency of cotrimoxazole maintained efficacy and reduced adverse reactions in HIV-positive patients with Pneumocystis carinii pneumonia (PCP).</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Drug Administration Schedule</subject><subject>Drugs</subject><subject>HIV Infections - complications</subject><subject>Humans</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pneumonia</subject><subject>Pneumonia, Pneumocystis - etiology</subject><subject>Pneumonia, Pneumocystis - prevention & control</subject><subject>Retrospective Studies</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV1rFDEUhoModVv9BwpBRPRiaj5nJjcFWWpbKLQU9TZkMieYMjsZk8zS9dc3wy4teOHVIZznvJw8B6F3lJxSQuuvhBBWKS74Z8W-KEIZq-5eoBWVUlYNrdlLtHpCXqPjlO7LkyhZH6EjKgVnVKzQeO6ct8busBl7nMMA0YwWcHDYjxnixucMY8ZbiGlOuDd-2GEbcvSb8GD-Fh67EPHt-hZPMUy_d4N58KnM4surX9UUks9-C3gy2ZeY9Aa9cmZI8PZQT9DP7-c_1pfV9c3F1frbdWUF5bkSnbDKudY0EmRnat5zwWRnjbPSWUUtYw2oxhFRRDAqFetI51hnlalV3Qh-gj7tc8tSf2ZIWW98sjAMZoQwJ92wltekJQX88A94H-Y4lt0044wT1aolTewhG0NKEZyeyv9N3GlK9HILvYjWi2itSl1uoe_K2PtD9txtoH8e2ssv_Y-HvknWDG4x79MTJplUUrUFO9tjUIRtPUSdbJFpofcRbNZ98P_f4xEwJaYk</recordid><startdate>19920201</startdate><enddate>19920201</enddate><creator>MacGregor, Rob Roy</creator><creator>Morgan, Amy S.</creator><creator>Graziani, Amy L.</creator><creator>Pietroski, Nancy A.</creator><creator>Frank, Ian</creator><creator>Braffman, Michael N.</creator><creator>Stern, John J.</creator><creator>Buckley, R.Michael</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>19920201</creationdate><title>Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients</title><author>MacGregor, Rob Roy ; Morgan, Amy S. ; Graziani, Amy L. ; Pietroski, Nancy A. ; Frank, Ian ; Braffman, Michael N. ; Stern, John J. ; Buckley, R.Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-4b4c9ff8a75e5ba63d3425bcafc5fc91c227e97f0401621592b0bf2bc9a696743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Drug Administration Schedule</topic><topic>Drugs</topic><topic>HIV Infections - complications</topic><topic>Humans</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pneumonia</topic><topic>Pneumonia, Pneumocystis - etiology</topic><topic>Pneumonia, Pneumocystis - prevention & control</topic><topic>Retrospective Studies</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MacGregor, Rob Roy</creatorcontrib><creatorcontrib>Morgan, Amy S.</creatorcontrib><creatorcontrib>Graziani, Amy L.</creatorcontrib><creatorcontrib>Pietroski, Nancy A.</creatorcontrib><creatorcontrib>Frank, Ian</creatorcontrib><creatorcontrib>Braffman, Michael N.</creatorcontrib><creatorcontrib>Stern, John J.</creatorcontrib><creatorcontrib>Buckley, R.Michael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MacGregor, Rob Roy</au><au>Morgan, Amy S.</au><au>Graziani, Amy L.</au><au>Pietroski, Nancy A.</au><au>Frank, Ian</au><au>Braffman, Michael N.</au><au>Stern, John J.</au><au>Buckley, R.Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>1992-02-01</date><risdate>1992</risdate><volume>92</volume><issue>2</issue><spage>227</spage><epage>229</epage><pages>227-229</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Medical records were reviewed retrospectively to determine if the decreased dosing frequency of cotrimoxazole maintained efficacy and reduced adverse reactions in HIV-positive patients with Pneumocystis carinii pneumonia (PCP).</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1543214</pmid><doi>10.1016/0002-9343(92)90122-R</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9343 |
| ispartof | The American journal of medicine, 1992-02, Vol.92 (2), p.227-229 |
| issn | 0002-9343 1555-7162 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72836080 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acquired immune deficiency syndrome AIDS AIDS/HIV Antibiotics. Antiinfectious agents. Antiparasitic agents Antiparasitic agents Biological and medical sciences Drug Administration Schedule Drugs HIV Infections - complications Humans Medical research Medical sciences Pharmacology. Drug treatments Pneumonia Pneumonia, Pneumocystis - etiology Pneumonia, Pneumocystis - prevention & control Retrospective Studies Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use |
| title | Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A44%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20tolerance%20of%20intermittent%20versus%20daily%20cotrimoxazole%20for%20PCP%20prophylaxis%20in%20HIV-positive%20patients&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=MacGregor,%20Rob%20Roy&rft.date=1992-02-01&rft.volume=92&rft.issue=2&rft.spage=227&rft.epage=229&rft.pages=227-229&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/0002-9343(92)90122-R&rft_dat=%3Cproquest_cross%3E72836080%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232309894&rft_id=info:pmid/1543214&rft_els_id=000293439290122R&rfr_iscdi=true |